轻/非活动性系统性红斑狼疮患者虽糖耐量正常但胰岛素抵抗与胰高血糖素水平升高
横断面研究纳入33例轻/非活动性女性SLE患者与16名年龄及BMI匹配的健康女性,行餐耐量试验评估胰岛素敏感性与β细胞功能。SLE组空腹胰岛素、HOMA-IR、胰岛素/葡萄糖比值反应、空腹及餐后胰高血糖素均高于对照组,但糖耐量、β细胞功能及骨骼肌GLUT-4转位保持正常。
要点
- 轻/非活动性SLE患者存在胰岛素抵抗和高胰高血糖素血症的双激素代谢异常。
- 尽管糖耐量正常且β细胞功能与骨骼肌GLUT-4转位保留,空腹及餐后胰高血糖素仍升高。
- 改善SLE患者胰岛素敏感性以降低2型糖尿病和心血管风险可能需要超越单纯针对胰岛素抵抗的策略。
核心结论
- 轻/非活动性SLE患者存在以胰岛素抵抗和高胰高血糖素血症为特征的双激素代谢异常,尽管糖耐量正常、β细胞功能及骨骼肌GLUT-4转位保留。
研究设计与样本
- 横断面研究纳入33例轻/非活动性成年女性SLE患者与16名年龄及BMI匹配的健康女性对照,均行餐耐量试验评估胰岛素敏感性与β细胞功能。
- 骨骼肌总及膜性胰岛素依赖性葡萄糖转运体4(GLUT-4)蛋白表达在SLE组10例与对照组5例中于餐耐量试验后行肌肉活检评估。
- 进一步测量包括炎症细胞因子、脂肪细胞因子、体力活动水平、体成分及食物摄入。
主要发现
- SLE组与对照组餐耐量试验后空腹血糖、葡萄糖反应及骨骼肌GLUT-4转位相似。
- SLE组空腹胰岛素水平较高(P=0.01;效应量[ES]1.2),稳态模型评估胰岛素抵抗(HOMA-IR)较高(P=0.03;ES 1.1)。
- SLE组餐耐量试验胰岛素/葡萄糖比值反应较高(P=0.02;ES 1.2),空腹胰高血糖素水平较高(P=0.002;ES 2.7),餐耐量试验胰高血糖素反应较高(P=0.0001;ES 2.6)。
- SLE组全身胰岛素敏感性Matsuda指数有降低趋势(P=0.06;ES -0.5)。
- 两组空腹胰岛素原/胰岛素比值及餐耐量试验胰岛素原/胰岛素比值反应相似(P>0.05),SLE组胰岛素生成指数较高(P=0.02;ES=0.9)。
临床怎么用
- 对轻/非活动性SLE患者应关注胰岛素抵抗和高胰高血糖素血症,即使糖耐量正常。
- 改善SLE患者胰岛素敏感性以降低2型糖尿病和心血管风险可能需要超越单纯针对胰岛素抵抗的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess insulin sensitivity in patients with systemic lupus erythematosus (SLE) in response to a meal tolerance test (MTT). METHODS: In this cross-sectional study, 33 adult females with mild/inactive SLE (SLE group) and 16 age- and body mass index-matched female healthy controls (CTRL group) underwent an MTT and were assessed for insulin sensitivity and beta cell function. Skeletal muscle protein expressions of total and membrane insulin-dependent glucose transporter 4 (GLUT-4) were also evaluated (SLE group: n = 10, CTRL group: n = 5); muscle biopsies were performed after MTT. Further measurements included inflammatory cytokines, adipocytokines, physical activity level, body composition, and food intake. RESULTS: SLE and CTRL groups showed similar fasting glucose, glucose response, and skeletal muscle GLUT-4 translocation after MTT. However, the SLE group demonstrated higher fasting insulin levels (P = 0.01; effect size [ES] 1.2), homeostatic model assessment insulin resistance (IR) (P = 0.03; ES 1.1), insulin-to-glucose ratio response to MTT (P = 0.02; ES 1.2), fasting glucagon levels (P = 0.002; ES 2.7), glucagon response to MTT (P = 0.0001; ES 2.6), and a tendency toward lower Matsuda index of whole-body insulin sensitivity (P = 0.06; ES -0.5) when compared with the CTRL group. Fasting proinsulin-to-insulin ratio and proinsulin-to-insulin ratio response to MTT were similar between groups (P > 0.05), while the SLE group showed a higher insulinogenic index when compared with the CTRL group (P = 0.02; ES = 0.9). CONCLUSION: We have identified that SLE patients had a bi-hormone metabolic abnormality characterized by increased IR and hyperglucagonemia despite normal glucose tolerance and preserved beta cell function and skeletal muscle GLUT-4 translocation. Strategies capable of ameliorating insulin sensitivity to reduce the risk of type 2 diabetes mellitus and cardiovascular disease in SLE may require more than targeting IR alone.
引用
- Miyake CNH, Gualano B, Dantas WS, et al. Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance. Arthritis Care Res (Hoboken). 2017. PMID: 28320046. doi:10.1002/acr.23237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。